Surveillance of bloodstream infection and antibiotic resistance in Phnom Penh, Cambodia (2007–2014)  by Phe, T. et al.
110 17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477
Type: Poster Presentation
Final Abstract Number: 41.086
Session: Poster Session I
Date: Thursday, March 3, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
Concentration dependent carbapenem
exposure alters the plasmid copy number
within nosocomial isolates of Escherichia coli
harboring blaNDM-1: A study from Northeast
India
D. Paul1,∗, D. Dhar2, A. Bhattacharjee1
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Background: Expansion of blaNDM-1 and its broad host range
results in the propagation of this resistance determinant within
different incompatibility group of plasmids. It is crucial to under-
stand how bacterial extra chromosomal entity responds in the
pathogen encoding the resistance gene when they are exposed
to carbapenem antibiotics. This study investigates the change in
plasmid copy number of blaNDM-1 under the pressure of different
concentration of carbapenem antibiotics within nosocomial iso-
lates of E. coli from a tertiary referral hospital of northeast India.
Methods & Materials: Clinical isolates of E. coli harboring
blaNDM-1 within three different incompatibility plasmid groups
viz; Inc F, Inc A/C and Inc K were grown under the exposure of
imipenem, meropenem and ertapenem with concentration of 0.5,
1, 2 and 4g/ml for each antibiotic. Plasmid was extracted for each
sample and quantitative real time PCR was carried out to estimate
the relative copy number of blaNDM-1 and fold change was normal-
ized against a housekeeping gene rpsel. Curing of different Inc type
plasmidwas done by treating the isolateswith different concentra-
tions of curing agents viz. sodium dodecyl sulfate, acridine orange
and ethidium bromide.
Results: It was observed that the copy number of blaNDM-1 gene
within Inc F and Inc A/C type of plasmids was consistently higher
as the concentration of imipenem and meropenem was increased
whereas in case of ertapenem it was vice versa. In Inc K type
of plasmid, the copy number of blaNDM-1 was consistently raised
only under the exposure of meropenem while with imipenem
and ertapenem, the copy number got reduced. Plasmids encoding
blaNDM-1 could be successfully eliminated after single treatment
with SDS and is considered as the most efﬁcient curing agent. The
curedmutantsbecamesusceptible to carbapenems,quinolonesand
to aminoglycosides antibiotics.
Conclusion: The study could establish that different car-
bapenem concentrations can alter the plasmid copy number
irrespective of their incompatibility types. Also, it underscores sta-
bility of different incompatible plasmids when exposed to a curing
agent. Thus, the current investigation is helpful in predicting the
vertical transmission dynamics of resistance determinants, which
will be key for infection control and slowing down expansion of
multidrug resistance in hospital settings.
http://dx.doi.org/10.1016/j.ijid.2016.02.281
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antibiotic resistance in Phnom Penh, Cambodia
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1 Sihanouk Hospital Center of HOPE, Phnom Penh,
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Background: Bloodstream infections (BSI) cause important
morbidity andmortalityworldwide. In Cambodia, there are limited
data on pathogens causing BSI and their antimicrobial resistance.
We describe the cumulative results of a prospective blood culture
surveillance study in an adults’ hospital in Phnom Penh, Cambodia
between July 2007 and December 2014.
Methods & Materials: Blood cultures (2×10ml) were per-
formed in adults presenting with systemic inﬂammatory response
syndrome (SIRS) at SihanoukHospital CentreofHOPE, PhnomPenh,
Cambodia. Isolates were identiﬁed using standard microbiological
techniques; antibiotic susceptibilities were assessed using disk dif-
fusionandMicroScan,withadditional E-test,D-test anddoubledisk
test, according to CLSI guidelines.
Results: A total of 16,815 pairs of blood-bottle samples from
12,092 patients yielded 1,467 clinically signiﬁcant organisms (CSO,
8.8%). Among them, 1160 (n=79.1%) were Gram-negative bacte-
ria, comprising Escherichia coli (n =436; 29.7%), Salmonella (n =291,
20.0%); Burkholderia pseudomallei (n =133, 9.0%) and Klebsiella spp.
(n =98; 6.7%). Among E. coli, we noted combined resistance to
amoxicillin, trimethoprim-sulfamethoxazole and ciproﬂoxacin in
256 (58.7%) isolates; 59.0% (190/322) isolates testedwere extended
spectrumbeta-lactamase (ESBL) producers, resistance to third gen-
eration cephalosporins increased from 50.0% in 2008 to 73.2% in
2014). In 2 patients, carbapenem-resistant Klebsiella pneumoniae
was isolated. For Burkholderia pseudomallei, no resistance towards
the drugs of use (i.e. ceftazidime, trimethoprim-sulfamethoxazole,
amoxicillin-clavulanic acid)was observed.Wenoted an emergence
of Salmonella Paratyphi A since mid-2012 which was still ongo-
ing at the end of the study period. For Salmonella Typhi (and other
Salmonella serotypes), there was a trend of increasing frequency of
reduced susceptibility to ciproﬂoxacin; ESBL was observed in 2 out
of 18 Salmonella Choleraesuis isolates.
AmongGram-positive CSO, Staphylococcus aureus (n =121, 8.2%)
was predominant; methicillin resistance was observed in 32/121
(26.4%) of S. aureus isolates and increased over time (15.4% versus
36.4% for the years 2008 versus 2014 respectively).
17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477 111
Conclusion: Sustained surveillance of BSI allows detection of
clinically relevant resistance patterns and outbreaks. BSI in Cam-
bodian adults is mainly caused by difﬁcult-to-treat pathogens. Our
ﬁndings have important implications for treatment guidelines and
urge for microbiological capacity building and solid interventions
to contain antibiotic resistance.
http://dx.doi.org/10.1016/j.ijid.2016.02.282
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Antibiotic sensitivity patterns among ESBL UTIs
in Sri Lanka
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Background: Extended-spectrum -lactamase (ESBL) produc-
ing organisms causing urinary tract infections (UTI) are increasing
in incidence and poses a major burden to health care requiring
treatment with expensive antimicrobials and prolonged hospi-
tal stay. The prevalence of ESBL producing organisms particularly
in the Asian region remains unknown. In a study carried out in
a tertiary care center in India,70/218(32.1%) clinical isolates of
Enterobacteriaceae were conﬁrmed as ESBL. Of them K. pneumo-
nia were the most common ESBL producers(46.4%), followed by E
coli (31.7%). Previous studies to evaluate antibiotic susceptibility
shows high sensitivity to meropenem (95-100%) with aminogly-
coside susceptibility ranging from 45-60%. Objective of this study
was to evaluate the antibiotic sensitivity patterns of ESBL UTIs in
Sri Lanka.
Methods & Materials: Patients with ESBL-UTI admitted to Pro-
fessorial Medical Unit, Colombo North Teaching Hospital, Ragama
over a period of 6 months from January-July 2015 were recruited
to the study. Their Urine culture and ABST reports were analysed
after obtaining informed written consent.
Results: There were 52 patientswho consented for the
study;males30 (57.7%),mean (SD) age 64.11 (12.59)years. The
most common organisms causing the ESBL-UTI were E. coli in
44(84.6%),followed by Klebsiella in 8 (15.4%) . The ESBL organ-
ismsweremostly sensitive to carbapenems;Meropenem50 (96.2%)
and Imipenem in 38(73.1%). The other sensitivity patterns were
Amikacin in30 (57.7%),Nitrofurantoin in24 (46.2%) andCeftriaxone
in 2 (3.8%). None were sensitive to Ceftazidime. Meropenem resis-
tance was found in 2 (3.8%) and wereE.coli. These two patients had
received multiple antibiotics including meropenem in the recent
past for recurrant UTI.
Conclusion: It is evident from the above data that Carbapenems
remain as the ﬁrst line therapy for the majority of UTIs caused by
ESBLproducing organisms in the local setting. However 3.8%preva-
lence ofmeropenem resistance among the study population should
drawattentionof clinicians andneeds implementation ofmeasures




Final Abstract Number: 41.089
Session: Poster Session I
Date: Thursday, March 3, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
Direct costs and length of stay in Carbapenem
resistant versus Carbapenem sensitive
Klebsiella pneumoniae infections in a tertiary
care hospital
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Background: This study was carried out to ﬁnd out the average
direct hospitalization cost and length of hospital stay for patients
infected with Carbapenem-resistant Klebsiella pneumonia (CRKp)
and compare it with that of patients infected with Carbapenem-
sensitive Klebsiella pneumonia (CSKp).
Methods & Materials: A cross sectional study was carried out
from January-December 2014 and the data for hospitalization cost
was collected for the patients with CRKp and CSKp infections from
the medicine ICU for 72 patients admitted to the hospital. The data
was analyzed for the site of infection, length of stay and average
direct hospitalization cost which was then compared between the
two groups.
Results: During the study period, 101 patients were diagnosed
withKlebsiella pneumoniae infection. 61.79%of the infectionswere
respiratory, 24.52% urinary tract- related, 13.2% systemic and 0.47%
skin and soft tissue-related. The mean age of the study popula-
tion was 51.7±15.7 years. The median length of stay for CRKp
was 12 (11; 23) days as compared to 8 (5.2; 13.2) days in CSKp
patients . The median direct hospitalization cost was calculated to
be INR 43,274 (24,898; 16,0315) in case of CRKp versus INR 23,452
(12,489; 47,349) in CSKp patients.
Conclusion: It was observed that the average cost of overall
therapy and the average no. of hospitalization days was higher
in CRKp group compared to CSKp group. Antibiotic resistance is a
growing phenomenon and the resistance to Carbapenems can lead
to increased burden of morbidity and treatment cost for patients.
http://dx.doi.org/10.1016/j.ijid.2016.02.284
